SDCBP2-AS1

Across TCGA pan-cancer cohorts, SDCBP2-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SDCBP2-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SDCBP2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SDCBP2-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and UCS show a favorable association.

READ, UCS, and KIRC are the cancer types where SDCBP2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	III,IV	0.724	0.254	.002	42	view →
UCS	OS	Median	III,IV	0.617	0.292	.006	36	view →
KIRC	DFS	Tertile	IV	0.160	0.486	.005	30	view →
KICH	DFS	Median	III,IV	0.299	1.000	.004	26	view →
PAAD	DFS	Quartile	All	0.579	0.205	.004	23	view →
COAD	DFS	Quartile	III,IV	0.334	0.901	.002	18	view →
LUAD	OS	Median	II,III,IV	0.308	0.171	.006	17	view →
SKCM	DFS	Median	All	0.258	0.148	<.001	16	view →
BLCA	DFS	Quartile	IV	0.237	0.545	.018	15	view →
ESCA	OS	Median	IV	0.222	0.698	.006	12	view →
LGG	OS	Median	All	0.770	0.850	.015	10	view →
ACC	DFS	Quartile	All	0.523	0.806	.027	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

SDCBP2-AS1–READ (OS)

Open the READ breakdown →